A prescription drug affordability board would lower prescription costs

1 February 2023 - Del. Rasoul is proposing Virginia create an independent panel of health care experts to review drug price ...

Read more →

Drug prices increase 5.6% as Government ramps up pressure to lower costs

2 February 2023 - Restrained increases come as US implements the Inflation Reduction Act. ...

Read more →

Enhertu launched as gastric cancer tertiary treatment in Korea, insurance benefits loading

2 February 2023 - In an environment where gastric cancer treatments are currently lacking, the approval of Enhertu (ingredient: trastuzumab ...

Read more →

Medexus secures public reimbursement for Cuvposa in Quebec

1 February 2023 - Medexus Pharmaceuticals wishes to inform investors that the company has reached an agreement with the provincial government ...

Read more →

Tezspire approved for self-administration in the US with a new pre-filled pen

2 February 2023 - First and only respiratory biologic without phenotype or biomarker limitations that offers the choice of administration ...

Read more →

Advanced breast cancer: now a significant added benefit for trastuzumab deruxtecan

2 February 2023 - New results from an early-initiated study show advantages in overall survival. ...

Read more →

Calliditas receives conditional marketing authorisation from UK MHRA for Kinpeygo in IgA nephropathy

2 February 2023 - Calliditas Therapeutics today announced that the MHRA of the United Kingdom has granted conditional marketing authorisation for ...

Read more →

Professor John Skerritt retirement

2 February 2023 - Today, Professor John Skerritt has announced his decision to retire from his position of Deputy Secretary ...

Read more →

FDA approves first oral treatment for anaemia caused by chronic kidney disease for adults on dialysis

1 February 2023 - Today, the US FDA approved Jesduvroq tablets (daprodustat) as the first oral treatment for anaemia caused by ...

Read more →

FLAG Therapeutics receives rare paediatric disease designation for FLAG-003 for the treatment of children with diffuse intrinsic pontine glioma

31 January 2023 - FLAG Therapeutics announced today that FLAG-003, an investigational small molecule therapy for the treatment of diffuse intrinsic ...

Read more →

Mark Cuban Cost Plus Drug Company and OncoPower team up to bring medication adherence and cost savings to cancer patients

30 January 2023 - Collaboration focuses on pricing transparency, affordable access, and engaging patients at home to ensure treatment adherence. ...

Read more →

Simcere’s COVID-19 pill goes on sale in China at less than half the price of Pfizer’s Paxlovid

31 January 2023 - The retail price of Simcere Pharmaceutical’s orally taken COVID-19 treatment, which was only approved to go ...

Read more →

Nintedanib esylate for the treatment of adults with idiopathic pulmonary fibrosis when forced vital capacity is above 80% predicted

1 February 2023 - Nintedanib esylate is recommended as an option for the treatment of adults with idiopathic pulmonary fibrosis ...

Read more →

ABPI response to new MHRA fees announced for 1 April 2023

1 February 2023 - These fee increases are an important step to ensuring the MHRA has the resources it needs ...

Read more →

Somatrogon for treating growth disturbance in people 3 years and over

1 February 2023 - Somatrogon is recommended as an option for the treatment of children 3 years of age and over ...

Read more →